Table 2.
The five drug classes most commonly involved in reconciliation errors detected on admission
| Therapeutic groups and subgroups (ATC classification) | n (%) |
| Nervous system (N) | 40 (24.5) |
| Psycholeptics (N05) | 13 |
| Analgesics (N02) | 10 |
| Psychoanaleptics (N06) | 10 |
| Antiepileptics (N03) | 6 |
| Anti-Parkinson drugs (N04) | 1 |
| Cardiovascular system (C) | 36 (22.1) |
| Lipid modifying agents (C10) | 9 |
| Diuretics (C03) | 8 |
| Beta-blocking agents (C07) | 6 |
| Agents acting on the renin-angiotensin system (C09) | 5 |
| Cardiac therapy (C01) | 4 |
| Calcium channel blockers (C08) | 4 |
| Alimentary tract and metabolism (A) | 25 (15.3) |
| Drugs for acid-related disorders (A02) | 12 |
| Drugs for constipation (A06) | 5 |
| Drugs for functional gastrointestinal disorders (A03) | 2 |
| Drugs used in diabetes (A10) | 2 |
| Mineral supplements (A12) | 2 |
| Antiemetics and antinauseants (A04) | 1 |
| Digestives, incl. enzymes (A09) | 1 |
| Blood and blood forming organs (B) | 25 (15.3) |
| Antithrombotic agents (B01) | 18 |
| Antianaemic preparations (B03) | 5 |
| Blood substitutes and perfusion solutions (B05) | 2 |
| Sensory organs (S) | 16 (9.8) |
| Ophthalmologicals (S01) | 16 |
| Total | 142/163 (87.1) |
ATC, anatomical therapeutic chemical.